[1] VAN HOUT F M A,VAN DER MEER P F,WIERSUM-OSSELTON J C,et al.Transfusion reactions after transfusion of platelets stored in PAS-B,PAS-C,or plasma:a nationwide comparison[J]. Transfusion,2018,58(4):1021-1027. [2] ANDREU G,BOUDJEDIR K,MULLER J Y,et al.Analysis of transfusion-related acute lung injury and possible transfusion-related acute lung injury reported to the French hemovigilance network from 2007 to 2013[J]. Transfus Med Rev,2018,32(1):16-27. [3] TYNUV M,FLEGEL W A Quality improvement with platelet additive solution for safer out-of-group platelet transfusions[J]. I mMunohematology,2019,35(3):108-115. [4] CAZENAVE J P,ISOLA H,WALLER C,et al.Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center:impact on patient outcomes and component utilization during a 3-year period[J]. Transfusion,2011,51(3):622-629. [5] 陈会友,曾四海,陶黎阳,等. 血小板保养液与血浆混合保存血小板的初步研究[J]. 中国输血杂志,2007,20(3):186-188. [6] 赵凤绵,张爱红,谭延伟,等. 血小板添加液延长血小板保存期的研究[J]. 中国输血杂志,2009,22(1):33-35. [7] 赵燕,赵海涛,韩威,等.M-sol血小板保存液对血小板体外保存期间质量的影响[J].中国输血杂志,2011,24(3):233-234. [8] 相平,高志刚,陈蓓怡,等.M-sol保存液添加L-肉碱对血小板体外保存的影响[J].中国输血杂志,2020,33(10):1038-1042. [9] GULLIKSSON H,AUBUCHON J P,VESTERINEN M,et al.Storage of platelets in additive solutions:a pilot in vitro study of the effects of potassium and magnesium[J]. Vox Sang,2002,82(3):131-136. [10] 卿芸,毛伟. 血小板添加剂的最新研究进展及其评估[J]. 国际检验医学杂志,2022,43(10):1260-1263. [11] CHAVARIN P,COGNASSE F,ARGAUD C,et al.In vitro assessment of apheresis and pooled buffy coat platelet components suspended in plasma and SSP+ photochemically treated with amotosalen and UVA for pathogen inactivation (INTERCEPT Blood System™)[J]. Vox Sang,2011,100(2):247-249. [12] DER MEER P F V. PAS or plasma for storage of platelets? A concise review[J]. Transfus Med,2016,26(5):339-342. [13] HORNSEY V S,MCCOLL K,DRU mMOND O,et al. Extended storage of platelets in SSP platelet additive solution[J]. Vox Sang,2006,91(1):41-46. [14] VETLESEN A,MIRLASHARI M R,TORSHEIM I A,et al.Platelet activation and residual activation potential during storage of hyperconcentrated platelet products in two different platelet additive solutions[J]. Transfusion,2005,45(8):1349-1355. [15] ZHANG J G,CARTER C J,DEVINE D V,et al.Comparison of a novel viscous platelet additive solution and plasma:preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates[J]. Vox Sang,2008,94(4):299-305. [16] ZHANG J G,CARTER C J,CULIBRK B,et al.Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma[J]. Transfusion,2008,48(5):847-856. [17] MATHUR A,SWAMY N,THAPA S,et al.Adding to platelet safety and life:platelet additive solutions[J]. Asian J Transfus Sci,2018,12(2):136-140. [18] FERNÁNDEZ-MUÑOZ H,CASTILLA-LLORENTE C,PLAZA E M,et al. Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution[J]. Blood Transfus,2018,16(3):273-278. |